<DOC>
	<DOCNO>NCT02867761</DOCNO>
	<brief_summary>The study hypothesis symptomatic current former smoker spirometric value within normal range ( post-bronchodilator FEV1/FVC≥0.70 post-BD FVC &lt; 80 % predict [ guard restrictive lung disease ] ) still derive symptomatic benefit long-acting bronchodilator therapy even though exclude current GOLD guideline recommendation .</brief_summary>
	<brief_title>RETHINC : REdefining THerapy In Early COPD Pulmonary Trials Cooperative</brief_title>
	<detailed_description>RETHINC 12-week multicenter , randomize , double-blind , placebo-controlled , parallel-group study ass efficacy safety indacaterol/glycopyrrolate 27.5/15.6 mcg inhale twice daily symptomatic current former smoker respiratory symptom despite preserved spirometry define CAT ≥ 10 post-bronchodilator FEV1/FVC ratio ≥0.70 , respectively .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Glycopyrrolate</mesh_term>
	<criteria>1 . Subject must able understand provide inform consent 2 . Age 4080 3 . ≥20 packyear smoke history 4 . Postbronchodilator FEV1/FVC ratio ≥0.70 5 . Baseline CAT≥10 1 . Inability unwillingness participant give write informed consent comply study protocol . 2 . Subject pregnant , breastfeeding , plan become pregnant . 3 . Active pulmonary infection prior pulmonary infection antibiotic and/or steroid treatment complete ≤4 week prior enrollment . 4 . PostBD FVC &lt; 80 % predict 5 . A primary diagnosis asthma establish study investigator base ATS/ERS criterion previously implement MACRO clinical trial . 6 . Known concomitant lung disease , pulmonary tuberculosis ( unless confirm chest xray longer active ) , clinically significant bronchiectasis . 7 . History ( family history ) long QT syndrome . 8 . History paroxysmal ( intermittent ) atrial fibrillation consider exclusion . Patients persistent atrial fibrillation define continuous atrial fibrillation least 6 month control rate control strategy ( i.e. , selective beta blocker , calcium channel blocker , pacemaker placement , digoxin ablation therapy ) least 6 month may consider inclusion . In patient , heart rate enrollment must &lt; 100/min . 9 . Patients BMI &lt; 15 40 kg/m2 . 10 . Patients diabetes Type I uncontrolled diabetes Type II . 11 . Patients , judgment investigator , clinically relevant laboratory abnormality clinically significant condition ( limited ) significant renal disease , psychiatric disease , gastrointestinal disease , unstable ischemic heart disease , arrhythmia ( exclude chronic stable atrial fibrillation ) , uncontrolled hypertension condition opinion investigator might compromise patient safety compliance , interfere evaluation , preclude completion study . 12 . Patients history lung cancer . 13 . Patients narrowangle glaucoma , symptomatic benign prostatic hyperplasia bladderneck obstruction severe renal impairment urinary retention . Benign Prostatic Hyperplasia ( BPH ) patient stable treatment consider . 14 . Any past current medical problem finding physical examination laboratory test list , , opinion investigator , may pose additional risk participation study , may interfere participant 's ability comply study requirement may impact quality interpretation data obtain study . 15 . Patients history hypersensitivity study drug drug similar chemical classification , include untoward reaction sympathomimetic amine inhale medication component thereof . 16 . Patients unable successfully use dry powder inhaler device perform spirometry measurement . 17 . Use investigational drug time enrollment within 30 day 5 halflives enrollment , whichever longer . 18 . Patients receive protocolspecified prohibit medications.. 19 . Patients receive protocolspecified prohibit COPD related medication ( require undergo require washout period prior enrollment ) .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>COPD</keyword>
	<keyword>Chronic Obstructive Pulmonary Disease</keyword>
	<keyword>Pulmonary Function Tests</keyword>
	<keyword>Current Smoker</keyword>
	<keyword>Former Smoker</keyword>
	<keyword>Chronic Obstructive Airway Disease</keyword>
	<keyword>Respiratory Symptoms</keyword>
</DOC>